9549918

4 known cases. View patent page →

Cases
4
Active
2
2 closed
Filed
2022–2026
Top venue
D. Delaware
3 cases

Filing activity

2022: 1 case1'22'23'242025: 1 case'252026: 1 case'26
Cases asserting US Patent 9549918 filed per year.

Veloxis Pharmaceuticals, Inc. v. Accord Healthcare, Inc. et al.

outcome not detailed
Docket:
1:22-cv-00909
Filed:
2022-07-07
Patents:9549918

The complaint alleged that the defendants' ANDA for generic tacrolimus extended-release tablets infringed on six Veloxis patents, including the '918 patent. Veloxis sought to block the manufacturing and marketing of the generic product.